eleostearic-acid and 12-hydroxy-5-8-10-heptadecatrienoic-acid

eleostearic-acid has been researched along with 12-hydroxy-5-8-10-heptadecatrienoic-acid* in 1 studies

Other Studies

1 other study(ies) available for eleostearic-acid and 12-hydroxy-5-8-10-heptadecatrienoic-acid

ArticleYear
In vitro effect of trichosanic acid, a major component of Trichosanthes japonica on platelet aggregation and arachidonic acid metabolism in human platelets.
    Prostaglandins, leukotrienes, and essential fatty acids, 1988, Volume: 31, Issue:2

    The in vitro effect of trichosanic acid (TCA; C18:3, omega-5), a major component of Trichosanthes japonica, on platelet aggregation and arachidonic acid (AA) metabolism in human platelets was studied. TCA dose-dependently suppressed platelet aggregation of platelet rich plasma and washed platelets. TCA decreased collagen (50 micrograms/ml)-stimulated production of thromboxane B2 (TXB2) and 12-hydroxyhepta-decatrienoic acid (HHT) in a dose-dependent manner, while that of 12-hydroxyeicosatetraenoic acid (12-HETE) was rather enhanced. The conversion of exogenously added [14C]AA to [14C]TXB2 and [14C]HHT in washed platelets was dose-dependently reduced by the addition of TCA, while that to [14C]12-HETE was increased. Similar observations were obtained when linolenic acid (LNA; C18:3, omega-3) was used. These results suggest that TCA may decrease TXA2 formation in platelets, probably due to the inhibition of cyclooxygenase pathway, and thereby reduce platelet aggregation.

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Arachidonic Acids; Blood Platelets; Chromatography, High Pressure Liquid; Collagen; Fatty Acids, Unsaturated; Humans; Hydroxyeicosatetraenoic Acids; In Vitro Techniques; Linolenic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Thromboxane B2

1988